Minder verlangen naar tabak
Referenties
- Perrine DM: The Chemistry of Mind-Altering Drugs; American Chemical Society, Washington, DC, 1997.
- Iizumi H et al: Effect of nicotine-administration on tyrosine hydroxylase-containing neuron in the rat forebrain; immunohistochemical study with semiquantitative morphometric analysis; Nihon Arukoru Yakubutsu Igakkai Zasshi 32(5):503-510, 1997. PMID: 9396226.
- Girod R et al: Facilitation of glutamatergic neurotransmission by presynaptic nicotinic acetylcholine receptors; Neuropharmacology 39(13):2715-2725, 2000. PMID: 11044742.
- Zhou FM et al: Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum: Nat Neurosci 4(12):1224-1229, 2001. PMID: 11713470.
- Fowler JS et al: Inhibition of monoamine oxidase B in the brains of smokers; Nature 379:733-736, 1996. PMID: 8602220.
- Court JA et al: Dopamine and nicotinic receptor binding and the levels of dopamine and homovanillic acid in human brain related to tobacco use; Neuroscience 87(1):63-78, 1998. PMID: 9722142.
- Geracioti TD Jr et al: Low CSF concentration of a dopamine metabolite in tobacco smokers: Am J Psychology 156(1):130-132, 1999. PMID: 9892309.
- Mansvelder HD et al: Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas; Neuron 33(6):905-919, 2002. PMID: 11906697.
- Easton J: Nicotine extends duration of pleasant effects of dopamine; The University of Chicago Chronicle; 21(12), March 28, 2002.
- Gant C, Lewis G: End Your Addiction Now; Warner Books Inc., New York, NY, 2002.
- Gant C: End your patient’s addiction: Orthomolecular strategies (Unpublished lecture); Orthomolecular Health-Medicine conference, San Francisco, CA, 2002.